1 / 36

Bronchial Astma

Bronchial Astma. Ibrahim Tawhari. Prepared by:. Scernario :. Khalid 14 years old come to the clinic c/o shortness of breath for one day duration. He is a known asthmatic patient for more than 8 years, he visits clinic frequently.

Télécharger la présentation

Bronchial Astma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bronchial Astma Ibrahim Tawhari. Prepared by:

  2. Scernario: • Khalid 14 years old come to the clinic c/o shortness of breath for one day duration. • He is a known asthmatic patient for more than 8 years, he visits clinic frequently. • His school performance is below average, with frequent absence from school due to his illness.

  3. What is Bronchial Asthma?? • It is a chronic inflammatory disorder of the airways resulting in EPISODES of: • Reversible bronchospasm airflow obstruction. • Associated with airway HYPER-RESPONSIVENESS to endogenous or exogenous stimuli.

  4. ASTHMA IN KSA

  5. Asthma in KSA: • A common problem especially in children. • The prevalence of asthma among school children in KSA: • Range: 4%-23%. • Riyadh: 10%. • Jeddah: 12%

  6. PATHOPHYSIOLOGY

  7. PATHOPHYSIOLOGY

  8. PATHOPHYSIOLOGY: • During an acute asthmatic attack:

  9. PATHOPHYSIOLOGY:

  10. TRIGGERS

  11. TRIGGERS: • URTIs. • Allergens / Irritants: Mould Pollens Pet dander House Dust Feather Smoking Air Pollution

  12. TRIGGERS: • Drugs: • Emotion & Anxiety: NSAIDs -Blockers Aspirin

  13. TRIGGERS: • Others: Cold Air Exercises GERD

  14. SIGNS & SYMPTOMS…

  15. SYMPTOMS & SIGNS: • Tachypnea, • Wheezing, • Chest tightness, • Cough (especially nocturnal), sputum production.

  16. RED FLAGS…

  17. RED FLAGS: Expiratory Effort Fatigue Cyanosis Silent Chest  LOC

  18. Respiratory Distress: • Nasal flaring, tracheal tug • Inability to speak • Accessory muscle use, intercostalindrawing • Pulsusparadoxus

  19. DIAGNOSIS

  20. DIAGNOSIS: • History: • Is it the first time??? Recurrent??? • If first attack  Hyperactive airway disease. • SOB, Cough, sputum,… • Nocturnal attacks? • Effect on daily activities?? • Frequency? • Look for any triggers… • Family History… • Drug History…

  21. DIAGNOSIS: • History: • Atopic manifestation: Atopy Triad

  22. DIAGNOSIS: • P/E: • General Appearance, • Vital signs: Tachypnea, pulsusparadoxus, fever,…??? • General Examination: • Cyanosis, eczema, nasal polyps, URTI, … • Local Examinations: • Inspection: • Palpation: • Auscultation: • Percussion

  23. DIAGNOSIS: • Investigations: • O2 saturation. • ABGs: •  PO2 during attack (V/Q mismatch). •  PCO2 in mild asthma (hyperventilation)… • But, normal or PCO2 ominous sign (resp. muscle fatigue). • PFTs: • May not be possible during attacks… • Done when patient is stable…

  24. DIAGNOSIS: • Investigations: • PFTs: • Spirometry: • FEV1: • Improvement with medications..

  25. MANAGEMENT

  26. Management: • Non-Pharmacologic Management: • Avoid allergens… • Education of the patient: • Features of disease… • Goal of management… • How to do self monitoring… • Red flags…

  27. Management: • Pharmacologic Management: • Symptomatic relief in ACUTE ATTACKS: • Short acting 2-agonists: albuterol, terbutalin, mataprotrenol,… • Anticholinergic bronchodilators… • Steroids… • Long acting 2-agonists: Salmetrol, formetrol,…

  28. Management: • Pharmacologic Management: • CHRONIC MANAGEMENT: • Long Term Prevention of Attacks… • Inhaled or oral steroids… • Anti-allergic: Na chromoglycate, Nidocromile,.. • Long acting 2-agonists: Salmetrol, Formetrol,… • Aminophyllins… • LT receptors antagonists: zileuton, zafirlukast, montilukast,..

  29. Management:

  30. Follow up

  31. Criteria of Controlled Asthma:

  32. Assessment of Control:

  33. THE END…. Thanks…

More Related